Women’s Health Report Assesses first-in-class innovation with focus on endometriosis, polycystic ovarian syndrome and cervical intraepithelial neoplasia

This report assesses first-in-class innovation across the women’s health therapy area, with a particular focus on three key indications: endometriosis, polycystic ovarian syndrome (PCOS) and cervical intraepithelial neoplasia (CIN).

Pune, India - March 14, 2018 /MarketersMedia/ —

The women’s health therapy area covers medical disorders that affect females only, primarily disorders of the female reproductive system, including those associated with menstruation, conception, pregnancy, childbirth and menopause. Many of these disorders are highly prevalent among the female population. Despite this, the women’s health market is relatively small. This reflects diagnostic barriers and high levels of non-treatment for women’s health disorders, as well as high levels of genericization and relatively limited innovation within recent decades.
Access Report Details at: https://www.themarketreports.com/report/frontier-pharma-womens-health-an-expanding-therapy-area-with-endometriosis-therapies-prominent-among-the-first-in-class-pipeline
Scope
• Many women’s health disorders are highly prevalent. How do epidemiology trends vary for endometriosis, PCOS and CIN?
• Innovation within women’s health has been relatively limited over recent decades. What are the most prominent unmet needs across this therapy area?
• There are 261 pipeline programs in active development for women’s health. What proportion of these products are first-in-class? How does first-in-class innovation vary by indication, development stage and molecular target class?
• Although the first-in-class pipeline is relatively modest in size it is considerably diverse with eight distinct molecular target classes represented. Which first-in-class targets have been identified as most promising for women’s health conditions?
• Over 200 licensing deals relating to women’s health have been completed since 2006. Do women’s health products typically attract high deal values? Which first-in-class products have prior deal involvement?
Inquire for more details at: https://www.themarketreports.com/report/ask-your-query/987871
Reasons To Buy
• Understand the current clinical and commercial landscape. This includes a comprehensive study of symptoms, epidemiology, etiology, pathophysiology, co-morbidities and complications, diagnosis and treatment options.
• Visualize the composition of the women’s health market in terms of dominant molecule types and molecular targets, highlighting what the current unmet needs are and how they can be addressed. This knowledge allows a competitive understanding of gaps in the current market.
• Analyze the women’s health pipeline and stratify by stage of development, molecule type and molecular target.
• Assess the therapeutic potential of first-in-class targets. Using a proprietary matrix, first-in-class products have been assessed and ranked according to clinical potential. Promising first-in-class targets have been reviewed in greater detail.
• Recognize commercial opportunities in the women’s health deals landscape by analyzing trends in licensing and co-development deals, and identifying women’s health therapies that have not yet been involved in deals and may offer potential investment opportunities.
Get this report at: https://www.themarketreports.com/report/buy-now/987871

Contact Info:
Name: Shirish Gupta
Email: sales@themarketreports.com
Organization: The Market Reports
Address: SF-29, Sacred World, Wanawadi
Phone: 16314071315

Source URL: https://marketersmedia.com/womens-health-report-assesses-first-in-class-innovation-with-focus-on-endometriosis-polycystic-ovarian-syndrome-and-cervical-intraepithelial-neoplasia/314337

For more information, please visit https://www.themarketreports.com/report/frontier-pharma-womens-health-an-expanding-therapy-area-with-endometriosis-therapies-prominent-among-the-first-in-class-pipeline%20%20

Source: MarketersMedia

Release ID: 314337

Latest News

Asian shares track Wall Street gains on robust US earnings

Jan 17, 2019

SINGAPORE — Asian shares were mostly higher Thursday after strong earnings reports lifted indexes on Wall Street. But a report that the U.S. was investigating China's Huawei for allegedly stealing trade secrets from American companies limited gains. KEEPING SCORE: Hong Kong's Hang Seng gained 0.4 percent to 27,000.43 and Australia's S&P ASX 200 rose 0.3 percent to 5,850.30.The Shanghai Composite index surged 0.5 percent to 2,582.19. Japan's Nikkei 225 index edged 0.1 percent lower to 20,417.97 while South Korea's Kospi added 0.2 percent to 2,111.06. Shares rose in Taiwan, Thailand and Indonesia but fell in Singapore. WALL STREET: Strong earnings...

World stocks rise but Britain slips on Brexit limbo

Jan 17, 2019

SINGAPORE — World stock markets mostly rose on Wednesday, but fell in Britain, as investors reacted to the parliamentary defeat of British Prime Minister Theresa May's plan for leaving the European Union. KEEPING SCORE: In Europe, Germany's DAX rose less than 0.1 percent to 10,892 and France's CAC 40 added 0.3 percent to 4,797. Britain's FTSE 100 sank 0.5 percent to 6,861. Wall Street was positioned for gains, with Dow and S&P 500 futures both gaining 0.1 percent. BREXIT VOTE: British Prime Minister Theresa May suffered a major setback Tuesday when lawmakers rejected a Brexit deal by 432 votes to...

Malaysia's 2018 auto sales rebounded, flat growth seen

Jan 17, 2019

KUALA LUMPUR, Malaysia — New vehicle sales in Malaysia rebounded last year after two straight years of contraction, thanks to a three-month tax holiday, but growth is likely to remain flat this year amid uncertainties over government policies, an automotive group said Wednesday. The Malaysian Automotive Association said 598,714 vehicles were sold last year, up 3.8 percent from 2017. It said this was largely due to an upsurge in demand from June to August 2018 after vehicle prices dropped when a new government that took power in May's general election scrapped an unpopular consumption tax. Prime Minister Mahathir Mohamad's government...

Asian stocks mixed on poor Japanese data, growth fears

Jan 17, 2019

SINGAPORE — Asian markets were mixed on Wednesday as poor Japanese data and worries about global growth put a damper on trading. KEEPING SCORE: Japan's Nikkei 225 index slipped 0.6 percent to 20,430.73 while South Korea's Kospi added 0.3 percent to 2,102.45. Hong Kong's Hang Seng fell 0.3 percent to 26,756.09. Australia's S&P ASX 200 rose 0.1 percent to 5,822.60.The Shanghai Composite index was flat at 2,568.88. Shares fell in Taiwan but rose in Singapore, Malaysia and Indonesia. WALL STREET: U.S. indexes climbed Tuesday to their highest level in a month after Chinese officials said measures were in place to...

Stocks edge up on Chinese growth plan, ahead of Brexit vote

Jan 17, 2019

SINGAPORE — Global stock markets mostly rose Tuesday as after Chinese officials set out plans to support the world's second-biggest economy through a slowdown. Investors were also looking at corporate earnings as well as a vote later by the British parliament on a Brexit deal that has drawn strong opposition at home. KEEPING SCORE: In Europe, Britain's FTSE 100 rose 0.1 percent to 6,860. Germany's DAX lost early gains to trade down 0.1 percent to 10,843 after new data showed the country's economy slowed last year to its weakest pace in five years. The CAC 40 in France was flat...

Penggerak pasaran mengikut TradingView

About Us

Duniaga is Malaysia’s top local source for business news and information where people head to stay connected with the business news. We give daily in-depth analysis on the business happenings in the country.

Contact us: sales[at]duniaga.com

Subscribe Now!